Evidence map›Paper›PMID 31799267›Full record

ArticleSkin appendage disorders2019

Development of Lichen Planopilaris-Like Alopecia following Occupational Exposure to Trichloroethylene and Tetrachloroethylene.

Dustin H Marks, Dina Hagigeorges, Athena J Manatis-Lornell, Ruth K Foreman, Maryanne M Senna

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Skin appendage disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Use of Hydroxychloroquine in Hair Disorders.Skin appendage disorders · 2023
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dustin H MarksDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Dina HagigeorgesDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Athena J Manatis-LornellDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ruth K ForemanDermatopathology Service, Massachusetts General Hospital, Boston, Massachusetts, USA.
Maryanne M SennaDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Massachusetts General Hospital · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe report a case of acute and severe lichen planopilaris (LPP)-like alopecia in a 35-year-old male construction worker following occupational exposure to trichloroethylene (TCE) and tetrachloroethylene (PCE). CASE REPORT: Two weeks after initiating ground-intrusive construction at a previous dry-cleaning facility site, the patient developed sudden scalp pruritus and associated patchy hair loss. As subsequent scalp biopsies revealed LPP, he was started on hydroxychloroquine at 200 mg twice daily and clobetasol solution once daily. Despite treatment, the patient's hair loss rapidly progressed to involve >95% of his scalp within 3 years. An official "work clean" policy report revealed high-concentration exposure to TCE and PCE.

conclusionAlthough causation cannot be proven, the close temporal relationship and rapid progression of LPP-like alopecia in an atypical patient demographic support a strong correlation between chemical exposure to TCE/PCE and scarring hair loss.

Indexed as

Chemical exposureCicatricial alopeciaGorlin syndromeLichen planopilarisPerchloroethyleneScarring alopeciaTetrachloroethyleneTrichloroethylene

Identifiers

PMID31799267
PMCPMC6883445
OpenAlexW2964453308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.